Insulin and testosterone operate as one interconnected system, not two separate stories. Low testosterone often predicts worsening insulin resistance over time, and metabolic dysfunction can suppress testosterone production at its source. The most reliable lever is metabolic health itself: weight management, structured training, and glycemic control. Testosterone therapy may have a role when androgen deficiency is clinically confirmed, not as a stand-in for metabolic care.
TL;DR:
- A 2024 trial found testosterone therapy improved insulin resistance and glucose by 2.1% at 30 weeks and 4.9% at 138 weeks.
- The trial involved hypogonadal men with metabolic syndrome who were not taking diabetes medication; it does not establish testosterone as a diabetes treatment.
- Sustained weight loss and resistance training are first-line measures: fat loss can raise testosterone, while muscle activity improves insulin sensitivity.
- Before therapy, clinicians confirm deficiency with symptoms and two separate morning testosterone tests, then recheck testosterone and hematocrit after 3 to 6 months.
Table of Contents
- How Insulin and Testosterone Are Connected at the Cellular Level
- What Longitudinal Studies and Clinical Trials Actually Show
- Lifestyle Change and Diabetes Medications: What Moves Both Markers
- Testosterone Therapy: What It Can and Cannot Do for Insulin Sensitivity
- Practical Monitoring: Tests That Matter and When to See a Clinician
- Perspective From Viridos: Metabolic Health as the Executive's Lever
- How the Insulin-Testosterone Relationship Affects Cognitive Performance
- Nutritional Strategies That Support Both Insulin Sensitivity and Testosterone
- Why Sleep and Stress Management Matter for Hormonal Balance
- What This Evidence Actually Tells Us
- Supporting Disciplined Monitoring With Viridos Membership
- FAQ
- Sources
How Insulin and Testosterone Are Connected at the Cellular Level
The relationship begins inside the testicle itself. Leydig cells, which manufacture testosterone, respond to insulin signaling as part of normal steroidogenesis. But when insulin levels run chronically high, that signaling turns counterproductive. Research on testicular tissue shows that elevated insulin can induce the orphan nuclear receptor DAX-1 in Leydig cells, a transcriptional repressor that suppresses the enzymes responsible for steroidogenesis. The practical implication is that insulin signaling may influence testosterone production at the source.
The picture gets more complex once body composition enters the equation. Obesity and elevated insulin are associated with lower sex hormone-binding globulin (SHBG), the protein that carries most circulating testosterone. Lower SHBG changes total testosterone readings independent of how much hormone the testes actually produce, which is why a single blood draw rarely tells the full story for a man carrying excess visceral fat.
A third pathway runs through adipose tissue itself. Fat is metabolically active, and obesity is associated with increased aromatase activity that can convert testosterone into estradiol. These signals may feed back into the hormonal axis that governs hormone production.
Three mechanisms worth tracking:
- Chronic hyperinsulinemia can suppress Leydig cell steroidogenesis through DAX-1 induction.
- Excess body fat is associated with lower SHBG, which can affect total testosterone measurements.
- Visceral fat raises aromatase activity and inflammatory signaling that further dampens the hormonal axis.
What Longitudinal Studies and Clinical Trials Actually Show
Cross-sectional snapshots can suggest correlation without proving direction. Longitudinal data settles that question more convincingly. A cohort study found that men in the lowest quartile of baseline total testosterone had higher insulin resistance at follow-up, independently of multiple covariates. This association suggests low testosterone may precede worsening insulin resistance, though it does not establish causation.
A 2024 randomized controlled trial found testosterone therapy reduced HOMA-IR and fasting glucose by 2.1% at 30 weeks and 4.9% at 138 weeks in men with metabolic syndrome not on antiglycemic therapy. That is a real, measurable effect, and it tells us TRT can nudge insulin sensitivity in the right direction for a specific population: hypogonadal men with metabolic syndrome who are not yet on diabetes medication.
What the trial does not show is testosterone therapy functioning as a glycemic treatment on par with established diabetes care. Effect sizes are modest, and outcomes vary considerably depending on the population studied. Men with simple obesity respond differently than men with established type 2 diabetes, and the outcome measured matters too: HOMA-IR, fasting glucose, and HbA1c do not always move together or to the same degree. Reading any single study as a universal verdict on "testosterone fixes insulin resistance" overstates what the evidence supports.
Lifestyle Change and Diabetes Medications: What Moves Both Markers
If one intervention has earned a place at the top of the list, it is sustained weight loss paired with structured exercise. Clinical evidence indicates that weight loss can raise testosterone in obese men, and some studies report that lifestyle-driven fat loss restores normal testosterone in affected men. Resistance training compounds the effect by improving insulin sensitivity in skeletal muscle, the body's largest reservoir for glucose disposal.
Diabetes medications tell a more mixed story. Small trials on metformin show inconsistent effects on testosterone, with some reporting modest increases in free testosterone and others showing no change. GLP-1 receptor agonists may support weight loss, but their effects on testosterone and the contribution of weight loss versus other mechanisms are not established by the evidence cited here.
Practical priorities for a man managing both markers:
- Treat sustained weight loss and resistance training as the first-line intervention, not a secondary measure.
- Expect antidiabetic medication effects on testosterone to vary and to depend heavily on the degree of accompanying weight loss.
- Track body composition changes alongside lab values rather than relying on a single hormone reading.
Our guide on training approaches that affect testosterone discusses exercise and testosterone.
Pro Tip: Prioritize clinically supervised, sustained weight loss and resistance training before considering any pharmacological approach to hormonal or metabolic gains.
Testosterone Therapy: What It Can and Cannot Do for Insulin Sensitivity
Testosterone replacement therapy may be considered for documented androgen deficiency, assessed through laboratory results and symptoms as detailed in testosterone therapy benefits. It should not be presented as a standalone treatment for insulin resistance or diabetes; the 2024 metabolic syndrome trial examined metabolic outcomes in a specific study population.
Within that appropriate population, trial data show a consistent pattern: modest HOMA-IR improvement, glycemic marker changes that vary by individual, and more reliable gains in body composition such as lean mass and reduced fat mass. How much a man benefits metabolically depends heavily on his baseline hormonal status and whether weight loss is happening alongside therapy.
Clinicians typically follow a structured monitoring sequence when TRT is appropriate:
- Confirm deficiency with two separate morning total testosterone measurements plus symptom assessment.
- Establish baseline metabolic markers, including fasting glucose and lipid panel.
- Recheck testosterone and hematocrit at 3 to 6 months.
- Monitor hematocrit, PSA when appropriate, and metabolic markers at regular intervals thereafter.
- Adjust or discontinue therapy if safety markers move outside acceptable ranges.
Practical Monitoring: Tests That Matter and When to See a Clinician
A disciplined approach to monitoring beats guesswork. The following tests give the clearest picture of where a man stands:
- Morning total testosterone, with repeat testing and SHBG measurement considered when clinically appropriate.
- Fasting glucose and HbA1c to establish glycemic baseline and trend.
- Fasting insulin or HOMA-IR when insulin resistance is clinically suspected.
- Lipid panel, hematocrit, and PSA when clinically appropriate.
Interpretation matters as much as the numbers themselves. SHBG shifts with obesity and age, which means total testosterone alone can mislead; a free or calculated free testosterone value often clarifies the picture. Our clinical guide to free testosterone testing walks through how to read these values correctly.
See an endocrinologist or men's health clinician when symptoms of low testosterone persist despite lifestyle changes, when insulin resistance markers remain elevated without clear explanation, or when medication interactions complicate the picture.
Perspective From Viridos: Metabolic Health as the Executive's Lever
We view metabolic stabilization, weight management, glycemic control, and resistance training, as the first-line strategy for hormonal resilience and sustained performance. Our Performance Journal offers content for disciplined men. Clinical evaluation should always precede any consideration of hormone therapy or targeted supplementation.
How the Insulin-Testosterone Relationship Affects Cognitive Performance
For men in demanding roles, the insulin-testosterone connection reaches beyond the lab panel into daily executive function. Insulin and testosterone are relevant to health, but the evidence cited here does not establish how they affect specific cognitive abilities such as attention or decision-making.
Insulin resistance and poorly controlled blood sugar warrant clinical attention. The evidence cited here does not establish that they cause mental fatigue, slower processing, or reduced focus in the ways described. Testosterone is important to health, but the evidence cited here does not establish that it determines motivation, initiative, or resilience at work.
Men concerned about both testosterone and insulin resistance can discuss their symptoms and test results with a clinician. The evidence cited here does not establish that the two conditions cause compounding cognitive symptoms or that metabolic changes improve cognitive steadiness. Executives managing board decisions, capital allocation, or high-stakes negotiations have little margin for the kind of variable energy and focus that unmanaged metabolic dysfunction produces.
Addressing the root metabolic picture, rather than chasing a single hormone number, is the more durable path to restoring the mental sharpness that high-performance roles demand.
Nutritional Strategies That Support Both Insulin Sensitivity and Testosterone
Diet can be considered as part of an overall approach to metabolic and hormonal health, though the evidence cited here does not establish that a single nutritional strategy reliably improves both markers.
Adequate protein can support lean muscle mass. Dietary fat supplies energy and nutrients, but the evidence provided here does not establish that specific fat types or low-fat diets determine testosterone output. Testosterone synthesis uses cholesterol as a precursor.
Choosing fiber-rich foods and limiting refined carbohydrates can be part of a balanced approach to glycemic health. The evidence cited here does not establish that these dietary changes directly suppress or restore Leydig cell function.
Caloric balance matters more than any single nutrient. Since excess body fat lowers SHBG and raises aromatase activity, a sustainable caloric deficit for men carrying excess weight tends to improve both insulin sensitivity and testosterone concentrations simultaneously. Micronutrient status may be relevant to overall health, but the evidence cited here does not establish a specific role for zinc, magnesium, or vitamin D in androgen production. Our guide on micronutrients for androgen health outlines a practical test-first approach to these nutrients.
Why Sleep and Stress Management Matter for Hormonal Balance
Sleep deprivation and chronic stress act on insulin and testosterone through the same hormonal circuitry, which makes them difficult to separate from nutrition and training in any serious discussion of metabolic health.
Sleep disruption and sustained stress can affect health and may interact with hormonal and metabolic regulation. The evidence cited here does not establish the specific cortisol effects described. For executives operating under continuous deadline pressure, this is not an abstract concern: chronic stress exposure compounds the same metabolic vulnerabilities already discussed.
Sleep itself carries a direct hormonal cost when restricted. Testosterone levels are influenced by sleep, but the evidence cited here does not establish what share of daily production occurs during sleep or how sleep duration independently affects synthesis.
Consistent sleep and recovery habits can be part of a broader approach to wellbeing, but should not be treated as a proven hormonal intervention. For men already managing demanding schedules, treating sleep as a fixed commitment rather than a flexible buffer is one of the more underused levers available.
What This Evidence Actually Tells Us
The conventional framing treats testosterone as the variable to fix and insulin resistance as a side issue, or treats the two as entirely separate concerns handled by different specialists. Neither framing survives contact with the longitudinal data. The relationship may run in both directions, and the evidence cited here supports considering metabolic health alongside hormonal status.
What's overrated is the expectation that testosterone therapy alone resolves insulin resistance, or that insulin management alone restores testosterone to its full potential. Trial effect sizes are real but modest. Sustained weight management and resistance training are practical areas to discuss with a clinician when addressing metabolic health.
For a man weighing where to start, the order matters: confirm the metabolic picture first, correct what lifestyle changes can correct, and only then evaluate whether true androgen deficiency remains. That sequence respects what the evidence actually supports, rather than what feels like the faster fix.
— Joakim
Supporting Disciplined Monitoring With Viridos Membership
Men who take this evidence seriously need more than information. We built our membership around supplementation for men who have already done the metabolic work or are doing it now, not as a substitute for clinical evaluation.
- Our Member and Professional plans (current prices are on our pricing page) include our small-batch, Swedish-produced sublingual formulation.
- Membership supports disciplined routines for men who already understand that metabolic health comes first.
- We recommend reviewing lab work with a clinician before starting any hormone-related therapy or targeted supplementation.
If you are evaluating where disciplined supplementation fits into a metabolic-first strategy, review our membership details or explore current plans and pricing to see what fits your routine.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
How do you lower insulin levels in the body?
Sustained weight loss, resistance and aerobic exercise, and reducing refined carbohydrate intake are the most consistent ways to lower insulin levels over time. Clinical evidence shows weight loss reliably improves insulin sensitivity and testosterone together in obese men. Medication such as metformin or GLP-1 receptor agonists may be added under clinical supervision when lifestyle measures alone are insufficient.
How does low testosterone affect blood sugar control?
Low testosterone is associated with, and may predict, higher insulin resistance over time, based on longitudinal cohort data tracking men over multiple years. The relationship appears bidirectional, meaning poor blood sugar control can also suppress testosterone through mechanisms including reduced SHBG and altered Leydig cell signaling.
Can insulin resistance be reversed naturally?
Insulin resistance can improve substantially through sustained weight loss, resistance training, and dietary changes that reduce glucose spikes, though the degree of improvement varies by individual and by how long the resistance has been present. Lifestyle intervention remains the most evidence-supported first step before considering medication.
When should I get tested for low testosterone or insulin resistance?
Testing is reasonable when symptoms such as persistent fatigue, reduced drive, or unexplained weight gain accompany concerns about blood sugar, or when routine labs show elevated fasting glucose or HbA1c. A morning total testosterone test, repeated for confirmation, alongside fasting glucose and HbA1c, gives a reliable starting picture for a clinician to interpret.
Sources
- Pubmed
- Insulin Directly Regulates Steroidogenesis via Induction of the Orphan Nuclear Receptor DAX-1 in Testicular Leydig Cells *